SINCALIDE 5 ug/5mL
sincalide · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Fresenius Kabi USA, LLC
No Recall History
Plain English
SINCALIDE is a injection, powder, lyophilized, for solution containing sincalide at 5 ug/5mL, taken intravenous. Manufactured by Fresenius Kabi USA, LLC.
Key Facts
- Brand Name
- SINCALIDE
- Generic Name
- sincalide
- NDC Code (Product)
63323-579- Manufacturer
- Fresenius Kabi USA, LLC
- Strength
- 5 ug/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA017697
- Drug Class
- Cholecystokinin Analog [EPC]
- Marketing Start
- 04/01/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective6 reports
no adverse event3 reports
cholecystitis acute2 reports
malaise2 reports
peripheral ischaemia2 reports
abdominal discomfort1 reports
accident1 reports
anxiety1 reports
biliary sepsis1 reports
blood pressure decreased1 reports
Frequently Asked Questions
What is SINCALIDE used for?
SINCALIDE contains sincalide. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is SINCALIDE a controlled substance?
SINCALIDE is not classified as a controlled substance by the DEA.
What is the generic name for SINCALIDE?
The generic name for SINCALIDE is sincalide. There are 3 other brand versions of sincalide.
What is the NDC code for SINCALIDE 5 ug/5mL?
The NDC (National Drug Code) for SINCALIDE 5 ug/5mL is 63323-579, listed by Fresenius Kabi USA, LLC.